A Phase I Dose Escalation Trial of MAGE-A3 and HPV-16 Specific Peptide Immunomodulatory Vaccines in Patients With Recurrent/Metastatic (RM) Squamous Cell Carcinoma of the Head and Neck (SCCHN).

Journal of Clinical Oncology - United States
doi 10.1200/jco.2014.32.15_suppl.e17014
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Nivolumab in the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (RM-SCCHN): A Report of 16 Cases at a Single Institution

International Journal of Practical Otolaryngology
2019English

Genetic Landscape of Metastatic and Recurrent Head and Neck Squamous Cell Carcinoma

Journal of Clinical Investigation
Medicine
2016English

A Phase II Study of Temsirolimus and Erlotinib in Patients With Recurrent and/or Metastatic, Platinum-Refractory Head and Neck Squamous Cell Carcinoma

Oral Oncology
Cancer ResearchOral SurgeryOncology
2013English

Socioeconomic Factors and Survival in Patients With Non-Metastatic Head and Neck Squamous Cell Carcinoma

Cancer Science
Cancer ResearchMedicineOncology
2017English

Cisplatin/Tegafur/Uracil/Irinotecan Triple Combination Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma: A Phase I/Ii Clinical Study

Oncologist
Cancer ResearchMedicineOncology
2016English

Pcn105 - Economic Burden of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Active8: A Randomized, Double-Blind, Placebo-Controlled Study of Chemotherapy Plus Cetuximab in Combination With TLR8 Agonist VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Analysis of Chemokine and Chemokine Receptor Expression in Squamous Cell Carcinoma of the Head and Neck (SCCHN) Cell Lines

Radiation and Environmental Biophysics
BiophysicsRadiationEnvironmental Science
2010English

Phase I Clinical Trial of Human Vascular Endothelial Growth Factor Receptor 1 Peptide Vaccines for Patients With Metastatic Renal Cell Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy